Skip to main content
. 2020 May 26;4(10):2325–2338. doi: 10.1182/bloodadvances.2020001466

Table 1.

Patient characteristics (N = 110)

Characteristic No. Median (range)
Sex
 Male 68
 Female 42
Age, y 12 (2-61)
 2-14 71
 15-61 39
Pretreatment disease burden
 Percent blasts in BM by morphology 8.75 (0-96)
 <5 42
 5 to ≤20 14
 >20 44
With EMD 23
 CNS leukemia 17
 CNS-2 5
 CNS-3 4
 Testicular leukemia 4
 Diffused EMD 3
 Single-site EMD 2
Complex cytogenetic 53
With fusion gene
 BCR-ABL 14
 TEL-AML1 8
 E2A-PBX1 6
 E2A-HLF 3
With gene mutation
 IKZF1 10
 TP53 12
 Other 39
Disease status
 Refractory (median of 3 cycles of chemotherapy) 14
 Relapsed (median of 10 cycles of chemotherapy) 96
Transplant status
 Posttransplant relapse 16
 No previous transplant 94